Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein

Biological Chemistry

Volumn 392, Issue 4, 2011, Pages 337-346

  Singh, Anubha ^a   Batra, Janendra K ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Eosinophil cationic protein (ECP); Eosinophilderived neurotoxin (EDN); Ribonuclease; RNase A

Indexed keywords

ARGININE; EOSINOPHIL CATIONIC PROTEIN; HISTIDINE; RIBONUCLEASE;

AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIPARASITIC ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ESCHERICHIA COLI; HEMOLYSIS; HUMAN; HUMAN CELL; LEISHMANIA DONOVANI; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPARASITIC AGENTS; BACILLUS SUBTILIS; BIOCATALYSIS; CELL LINE; CELL MEMBRANE; CYTOTOXINS; EOSINOPHIL CATIONIC PROTEIN; ERYTHROCYTES; ESCHERICHIA COLI; HEMOLYSIS; HUMANS; LEISHMANIA DONOVANI; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION;

EID: 79955462769     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2011.037     Document Type: Article

References (39)

1. Ackerman, S.J., Gleich, G.J., Loegering, D.A., Richardson, B.A., and Butterworth, A.E. (1985). Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 34, 735-745. (Pubitemid 16237019)
2. Boix, E., Nogués, M.V., Schein, C.H., Benner, S.A., and Cuchillo, C.M. (1994). Reverse transphosphorylation by ribonuclease A needs an intact p2-binding site. Point mutations at Lys-7 and Arg-10 alter catalytic properties of the enzyme. J. Biol. Chem. 269, 2529-2534.
3. Boix, E., Leonidas, D.D., Nikolovski, Z., Nogués, M.V., Cuchillo, C.M., and Acharya, K.R. (1999a). Crystal structure of eosinophil cationic protein at 2.4 Å resolution. Biochemistry 38, 16794-16801.
4. Boix, E., Nikolovski, Z., Moiseyev, G.P., Rosenberg, H.F., Cuchillo, C.M., and Nogués, M.V. (1999b). Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity. J. Biol. Chem. 274, 15605-15614.
5. Boix, E., Carreras, E., Nikolovski, Z., Cuchillo, C.M., and Nogués, M.V. (2001). Identification and characterization of human eosinophil cationic protein by an epitope-specific antibody. J. Leukoc. Biol. 69, 1027-1035. (Pubitemid 32577907)
6. Bond, M.D. (1988). An in vitro binding assay for angiogenin using placental ribonuclease inhibitor. Anal. Biochem. 173, 166-173.
7. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
8. Buchner, J., Pastan, I., and Brinkmann, U. (1992). A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205, 263-270.
9. Carreras, E., Boix, E., Rosenberg, H.F., Cuchillo, C.M., and Nogués, M.V. (2003). Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein. Biochemistry 42, 6636-6644. (Pubitemid 36666104)
10. Domachowske, J.B. and Rosenberg, H.F. (1997). Eosinophil inhibit retroviral transduction of human target cells by a ribonucleasedependent mechanism. J. Leukoc. Biol. 62, 363-368. (Pubitemid 27431607)
11. Domachowske, J.B., Dyer, K.D., Adams, A.G., Leto, T.L., and Rosenberg, H.F. (1998). Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res. 26, 3358-3363. (Pubitemid 28321399)
12. Fredens, K., Dahl, R., and Venge, P. (1982). The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J. Allergy Clin. Immunol. 70, 361-366. (Pubitemid 13233284)
13. Gullberg, U., Widegren, B., Arnason, U., Egesten, A., and Olsson, I. (1986). The cytotoxic eosinophil cationic protein (ECP) has ribonuclease activity. Biochem. Biophys. Res. Commun. 139, 1239-1242. (Pubitemid 17168514)
14. Hamann, K.J., Barker, R.L., Loegering, D.A., and Gleich, G.J. (1987). Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. J. Parasitol. 73, 523-529.
15. Kolbanovskaya, E.Y., Morozov, N.Y., Gavryushov, S.A., Ilin, V.A., Beintema, J.J., Wlodawer, A., and Karpeisky, M.Y. (1993). Structural-functional analysis of ribonuclease A and related proteins. Mol. Biol. 27, 821-836.
16. Kunkel, T.A., Roberts, J.D., and Zakour, R.A. (1987). Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154, 367-382.
17. Lehrer, R.I., Szklarek, D., Barton, A., Ganz, T., Hamann, K.J., and Gleich, G.J. (1989). Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J. Immunol. 142, 4428-4434. (Pubitemid 19162336)
18. Maeda, T., Mahara, K., Kitazoe, M., Futami, J., Takidani, A., Kosaka, M., Tada, H., Seno, M., and Yamada, H. (2002). RNase 3 (ECP) is an extraordinarily stable protein among human pancreatic- type RNases. J. Biochem. 132, 737-742. (Pubitemid 35408496)
19. Mallorqui-Fernandez, G., Pous, J., Peracaula, R., Aymami, J., Maeda, T., Tada, H., Yamada, H., Seno, M., de Llorens, R., Gomis- Ruth, F.X., et al. (2000). Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 Å resolution. J. Mol. Biol. 300, 1297-1307.
20. McLaren, D.J., McKean, J.R., Olsson, I., Venges, P., and Kay, A.B. (1981). Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro. Parasite Immunol. 3, 359-373. (Pubitemid 12216776)
21. Molina, H.A., Kierszenbaum, F., Hamann, K.J., and Gleich, G.J. (1988). Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 38, 327-334. (Pubitemid 18086114)
22. Motojima, S., Frigas, E., Loegering, D.A., and Gleich, G.J. (1989). Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am. Rev. Respir. Dis. 139, 801-805. (Pubitemid 19084409)
23. Pearson, R.D., Uydess, I.L., and Chapman, S.W. (1987). Interaction of human eosinophils with Leishmania donovani. Ann. Trop. Med. Parasitol. 81, 735-739. (Pubitemid 18073238)
24. Pimenta, P.F.P., Dos Santos, M.A.V., and De Souza, W. (1987). Fine structure and cytochemistry of the interaction between Leishmania mexicana amazonensis and rat neutrophils and eosinophils. J. Submicrosc. Cytol. 19, 387-395.
25. Rosenberg, H.F. (1995). Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J. Biol. Chem. 270, 7876-7881.
26. Rosenberg, H.F., Ackerman, S.J., and Tenen, D.G. (1989a). Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J. Exp. Med. 170, 163-176. (Pubitemid 19179702)
27. Rosenberg, H.F., Tenen, D.G., and Ackerman, S.J. (1989b). Molecular cloning of the human eosinophil-derived neurotoxin: A member of the ribonuclease gene family. Proc. Natl. Acad. Sci. USA 86, 4460-4464. (Pubitemid 19164574)
28. Sanger, F., Nicklen, S., and Coulson, A.R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
29. Sikriwal, D., Seth, D., and Batra, J.K. (2009). Role of catalytic and non-catalytic subsite residues in ribonuclease activity of human eosinophil-derived neurotoxin. Biol. Chem. 390, 225-234.
30. Slifman, N.R., Loegering, D.A., McKean, D.J., and Gleich, G.J. (1986). Ribonuclease activity associated with human eosinophil derived neurotoxin and eosinophil cationic protein. J. Immunol. 137, 2913-2917. (Pubitemid 17177799)
31. Sorrentino, S., Glitz, D.G., Hamann, K.J., Loegering, D.A., Checkel, J.L., and Gleich, G.J. (1992). Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity. J. Biol. Chem. 267, 14859-14865.
32. Tai, P.C., Ackerman, S.J., Spry, C.J., Dunnette, S., Olsen, E.G., and Gleich, G.J. (1987). Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1, 643-647. (Pubitemid 17038903)
33. Torrent, M., Navarro, S., Moussaoui, M., Nogués, M.V., and Boix, E. (2008). Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans. Biochemistry 47, 3544-3555. (Pubitemid 351399243)
34. Torrent, M., de la Torre, B.G., Nogués, V.M., Andreu, D., and Boix, E. (2009). Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem. J. 421, 425-434.
35. Torrent, M., Nogués, M.V., and Boix, E. (2011). Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site. J. Mol. Recognit. 24, 90-100.
36. Venge, P., Bystrom, J., Carlson, M., Hakansson, L., Karawacjzyk, M., Peterson, C., Seveus, L., and Trulson, A. (1999). Eosinophil cationic protein (ECP): Molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin. Exp. Allergy 29, 1172-1186. (Pubitemid 29406464)
37. Waters, L.S., Taverne, J., Tai, P.C., Spry, C.J., Targett, G.A., and Playfair, J.H. (1987). Killing of Plasmodium falciparum by eosinophil secretory products. Infect. Immun. 55, 877-881. (Pubitemid 17035420)
38. Yazdanbakhsh, M., Tai, P.C., Spry, C.J., Gleich, G.J., and Roos, D. (1987). Synergism between eosinophil cationic protein and oxygen metabolites in killing of schistosomula of Schistosoma mansoni. J. Immunol. 138, 3443-3447. (Pubitemid 17071931)
39. Young, J.D., Peterson, C.G., Venge, P., and Cohn, Z.A. (1986). Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321, 613-616. (Pubitemid 16042213)